In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Study Group on Peripartum Cardiomyopathy

Learn more about the purpose of this group and who its members are

Heart Failure (HF)

In June 2009, the Study Group on Peripartum Cardiomyopathy was formed by the Heart Failure Association of the European Society of Cardiology. This Study Group consists of experts from cardiology, basic sciences, intensive care, obstetrics and gynecology, imaging, genetics and other disciplines.

Activities and links

Web links for information

Information Flyer to download

We feel that such a group can promote ongoing interest and research into this disease of unknown etiology and facilitate lessons to be learned relevant to other conditions. Spread the word and create a network by putting up this Information Flyer.

EURObservational Research Programme: Peripartum Cardiomyopathy Registry

The primary objective of this world-wide registry on PPCM is to establish the clinical epidemiology and the diagnostic/therapeutic processes of women suffering from that condition as well as collecting information of their off-springs.

To receive information on how to participate in this registry, please contact the EURObservational Research Programme via the contact form. 


Participating centres will be able to receive newsletters and could consider participating in related PPCM companion studies on genetics, biomarkers and device therapy.

LAtest Publication in 2015

Peripartum cardiomyopathy: current management and future perspectives: European Heart Journal



  Prof. J. Bauersachs FESC (Hannover, DE) email

  Prof. K. Sliwa-Hahnle FESC (Cape Town, South Africa)


Study Group members

D Hilfiker-Kleiner (Hannover, DE)

A Mebazaa (Paris, FR)

F Mouquet (Lille, FR)

M Petrie (Glasgow, GB)

V Regitz-Zagrosek (Berlin, DE)

M Schaufelberger (Gothenburg, SE)

P Seferovic (Belgrade, RS)

E Kraigher-Krainer (Graz, AT)

K van Spaendonck-Zwarts  (Groningen, NL)

P van der Meer (Groningen, NL)


U Elkayam (Los Angeles, US)

K Bachelier (Homburg/Saar, DE)

A Mbakwem (Lagos, NG)

J McMurray (Glasgow, GB)

A Shah (London, GB)

L Tavazzi  (Cotignola, IT)

D van Veldhuisen (Gronongen, NL)


  • We aim to establish a platform where current knowledge on peripartum cardiomyopathy based on experimental and clinical studies is summarized and regularly up-dated, for example in form of consensus papers.
  • We will raise awareness of this uncommon but devastating problem by promoting sessions at international and national congresses and publishing articles in national and international journals.
  • We plan to coordinate the collection and analysis of data internationally for better understanding of the condition.
  • We will meet regularly to discuss and update management strategies for peripartum cardiomyopathy, with a focus on novel diagnostic and therapeutic approaches.
  • We will provide information and contact addresses on our webpage for physicians and patients concerned about peripartum cardiomyopathy.